NewAmsterdam Pharma Co N.V. (NAMS) stock
NAMSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NAMSW
$19.39−0.07 (-0.36%)
Close on Nov 17, 2026Market cap $2.32BP/E –Yield –
NewAmsterdam Pharma total assets
Total assets on the balance sheet at the end of each period.
NewAmsterdam Pharma's total assets was $704.45M at Jun 30, 2026. For fiscal 2025 it was $769.28M, down 11.0% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $769.28M | -11.0% |
| FY2024 | Dec 31, 2024 | $864.62M | +149.1% |
| FY2023 | Dec 31, 2023 | $347.10M | -27.5% |
| FY2022 | Dec 31, 2022 | $478.50M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $704.45M | -13.6% |
| Q1 FY2026 | Mar 31, 2026 | $732.64M | -10.5% |
| Q4 FY2025 | Dec 31, 2025 | $769.28M | -11.0% |
| Q3 FY2025 | Sep 30, 2025 | $786.43M | +79.1% |
| Q2 FY2025 | Jun 30, 2025 | $815.11M | +82.5% |
| Q1 FY2025 | Mar 31, 2025 | $818.41M | +67.5% |
| Q4 FY2024 | Dec 31, 2024 | $864.62M | +149.1% |
| Q3 FY2024 | Sep 30, 2024 | $439.19M | -8.2% |
| Q2 FY2024 | Jun 30, 2024 | $446.69M | – |
| Q1 FY2024 | Mar 31, 2024 | $488.46M | – |
| Q4 FY2023 | Dec 31, 2023 | $347.10M | – |
| Q4 FY2022 | Dec 31, 2022 | $478.50M | – |
See a number that looks wrong?